Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations
Patrick M. Brunner, Ariel Israel, Ning Zhang, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 141, Iss. 6, pp. 2094-2106
Open Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

Atopic dermatitis endotypes and implications for targeted therapeutics
Tali Czarnowicki, Helen He, James G. Krueger, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 143, Iss. 1, pp. 1-11
Open Access | Times Cited: 483
The microbiome in patients with atopic dermatitis
Amy S. Paller, Heidi H. Kong, Patrick C. Seed, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 143, Iss. 1, pp. 26-35
Open Access | Times Cited: 408
The atopic march and atopic multimorbidity: Many trajectories, many pathways
Amy S. Paller, Jonathan M. Spergel, Paola Mina‐Osorio, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 143, Iss. 1, pp. 46-55
Open Access | Times Cited: 337
Molecular Mechanisms of Atopic Dermatitis Pathogenesis
Jowita Sroka-Tomaszewska, Magdalena Trzeciak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4130-4130
Open Access | Times Cited: 334
A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics
Yik Weng Yew, Jacob P. Thyssen, Jonathan I. Silverberg
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 2, pp. 390-401
Closed Access | Times Cited: 234
Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
Hidemi Nakagawa, Osamu Nemoto, Atsuyuki Igarashi, et al.
Journal of the American Academy of Dermatology (2020) Vol. 82, Iss. 4, pp. 823-831
Open Access | Times Cited: 195
JAK Inhibitors for Atopic Dermatitis: An Update
Helen He, Emma Guttman‐Yassky
American Journal of Clinical Dermatology (2018) Vol. 20, Iss. 2, pp. 181-192
Closed Access | Times Cited: 191
Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation
R.D. Sanyal, Ana B. Pavel, Jacob W. Glickman, et al.
Annals of Allergy Asthma & Immunology (2018) Vol. 122, Iss. 1, pp. 99-110.e6
Closed Access | Times Cited: 176
Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions”
Wendy F. Davidson, Donald Y.M. Leung, Lisa A. Beck, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 143, Iss. 3, pp. 894-913
Open Access | Times Cited: 174
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
Patrick M. Brunner, Ana B. Pavel, Saakshi Khattri, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 143, Iss. 1, pp. 142-154
Open Access | Times Cited: 166
Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type–specific immune regulation in atopic dermatitis
Thomas B. Rojahn, Vera Vorstandlechner, Thomas Krausgruber, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 5, pp. 1056-1069
Closed Access | Times Cited: 156
Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis
Emma Guttman‐Yassky, Aisleen Diaz, Ana B. Pavel, et al.
JAMA Dermatology (2019) Vol. 155, Iss. 12, pp. 1358-1358
Open Access | Times Cited: 152
Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis
Helen He, Robert Bissonnette, Jianni Wu, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 1, pp. 199-212
Closed Access | Times Cited: 149
Cutaneous barrier dysfunction in allergic diseases
Donald Y.M. Leung, Evgeny Berdyshev, Elena Goleva
Journal of Allergy and Clinical Immunology (2020) Vol. 145, Iss. 6, pp. 1485-1497
Open Access | Times Cited: 141
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults
Yael Renert‐Yuval, Ester Del Duca, Ana B. Pavel, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 1, pp. 148-163
Open Access | Times Cited: 115
The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment
Paola Facheris, Jane Jeffery, Ester Del Duca, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 5, pp. 448-474
Open Access | Times Cited: 105
Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation
Aurélien Trompette, Julie Pernot, Olaf Perdijk, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 5, pp. 908-926
Open Access | Times Cited: 102
Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis
Evgeny Berdyshev, Elena Goleva, Robert Bissonnette, et al.
Allergy (2022) Vol. 77, Iss. 11, pp. 3388-3397
Closed Access | Times Cited: 73
Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets
Luca Fania, Gaia Moretta, Flaminia Antonelli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2684-2684
Open Access | Times Cited: 70
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 64
Atopic dermatitis: Pathophysiology, microbiota, and metabolome – A comprehensive review
Shahnawaz Mohammad, Md Rezaul Karim, Safia Iqbal, et al.
Microbiological Research (2024) Vol. 281, pp. 127595-127595
Closed Access | Times Cited: 18
Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 2
Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches
Matthew Moyle, Ferda Cevikbas, Jamie L. Harden, et al.
Experimental Dermatology (2019) Vol. 28, Iss. 7, pp. 756-768
Open Access | Times Cited: 140
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
Ana B. Pavel, Teresa Song, Hyun Je Kim, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 4, pp. 1011-1024
Open Access | Times Cited: 110
The oral Janus kinase/spleen tyrosine kinase inhibitorASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
Robert Bissonnette, Catherine Maari, Seth Forman, et al.
British Journal of Dermatology (2019) Vol. 181, Iss. 4, pp. 733-742
Open Access | Times Cited: 109
Page 1 - Next Page

Scroll to top